Last updated: April 30, 2021
Sponsor: Brigham and Women's Hospital
Overall Status: Active - Recruiting
Phase
4
Condition
Blood Clots
Treatment
N/AClinical Study ID
NCT03473132
2017P001254
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- LVAD on warfarin requiring temporary interruption of anticoagulation for procedures
Exclusion
Exclusion Criteria:
- recent thrombotic event
Study Design
Total Participants: 50
Study Start date:
March 15, 2018
Estimated Completion Date:
March 31, 2022
Study Description
Connect with a study center
Brigham and Women's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.